| Literature DB >> 24936147 |
Julia Vormbrock1, Jeanette Liebeton1, Sophia Wirdeier1, Axel Meissner1, Thomas Butz1, Hans-Joachim Trappe1, Gunnar Plehn2.
Abstract
INTRODUCTION: Although chronic pulmonary hypertension and right ventricular (RV) function carry important functional and prognostic implications in idiopathic dilated cardiomyopathy (IDC), little information on RV muscle mass (RVMM) and its determinants has been published.Entities:
Keywords: Right ventricular muscle mass; heart failure; myocardial hypertrophy.
Mesh:
Year: 2014 PMID: 24936147 PMCID: PMC4057489 DOI: 10.7150/ijms.6961
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Baseline parameters and RV mass and RV mass indexes in IDC patients and control group
| Parameter | control group | IDC | Significance |
|---|---|---|---|
| patients (n) | 13 | 35 | |
| age (years) | 59.84 ± 14.54 | 60.34 ± 12.66 | 0.91 |
| height (cm) | 168.33 ± 9.55 | 176.46 ± 7.11 | 0.02 |
| weight (kg) | 76.25 ± 14.85 | 90.65 ± 15.35 | 0.007 |
| RVEF (%) | 39.22 ± 6.41 | 27.98 ± 12.17 | 0.003 |
| RVEDV (ml) | 103.46 ± 35.11 | 161.34 ± 49.29 | 0.001 |
| RVESV (ml) | 61.69 ± 18.66 | 115.69 ± 42.99 | < 0.001 |
| RVMM (g) | 39.62 ± 10.11 | 49.11 ± 28.48 | 0.25 |
| RVMMI (g/m2) | 21.03 ± 4.37 | 23.18 ± 11.80 | 0.36 |
| RVMM/RVEDV (g/ml) | 0.40 ± 0.11 | 0.29 ± 0.14 | 0.017 |
| RVMM-AI | 1.81 ± 0.41 | 2.00 ± 1.04 | 0.003 |
| IVMR (RVMM/LVMM) | 0.42 ± 0.07 | 0.26 ± 0.11 | < 0.001 |
| LVMM (g) | 94.38 ± 23.98 | 183.60 ± 63.15 | < 0.001 |
| LVEF (%) | 64.54 ± 5.19 | 19.93 ± 6.51 | < 0.001 |
| LVEDV (ml) | 96.69 ± 25.70 | 292.17 ± 103.93 | < 0.001 |
| LVESV (ml) | 35.15 ± 13.01 | 229.34 ± 96.28 | < 0.001 |
| LVMM/LVEDV (g/ml) | 0.99 ± 0.19 | 0.64 ± 0.17 | < 0.001 |
| LVMMI (g/m2) | 50.08 ± 10.29 | 88.57 ± 27.65 | < 0.001 |
| LVMM/BSA-1.4 | 39.0 ± 7.50 | 66.3 ± 20.5 | 0.002 |
BSA = body surface area; CI = cardiac index; HR = heart rate; IVMR = interventricular mass ratio; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVMM/BSA-1.4 = left ventricular muscle mass based on allometric normalization; LVMM = left ventricular muscle mass; LVMMI = left ventricular muscle mass normalized to body surface area; PAMP = pulmonary artery mean pressure; PCWP = pulmonary capillary wedge pressure; RRdia = arterial diastolic pressure; RRsys = arterial systolic pressure; RVEDV = right ventricular end-diastolic volume; RVEF =right ventricular ejection fraction; RVESV = right ventricular end-systolic volume; RVMM-AI = right ventricular muscle mass corrected by age, mass and height; RVMM = right ventricular muscle mass; RVMMI = right ventricular muscle mass normalized to body surface area
Anthropometric, hemodynamic and MRI data in patient subgroups based on the distribution of RVMM-AI
| subgroup A (≤ 1.17 ) | subgroup B | subgroup C (> 2.51) | p | |
|---|---|---|---|---|
| patients (n) | 11 | 12 | 12 | |
| age (years ± SD) | 56.5 ± 11 | 62.3 ± 16.3 | 61.8 ± 9.7 | 0.50 |
| height (cm ± SD) | 174.3 ± 6.4 | 176.3 ± 8.0 | 178.6 ± 6.7 | 0.36 |
| weight (kg ± SD) | 80.1 ± 11.9 | 91.2 ± 12.1 | 98.4 ± 16.6 | 0.01 |
| NYHA-class | 2.5 ± 0.5 | 2.5 ± 0.5 | 3.0 ± 0.8 | 0.13 |
| PAMP (mmHg ± SD) | 16.7 ± 9.5 | 16.9 ± 9.8 | 25.4 ± 12.4 | 0.11 |
| PCWP (mmHg ± SD) | 9.7 ± 9.2 | 10.5 ± 9.3 | 13.5 ± 9.3 | 0.61 |
| RRsys (mmHg ± SD) | 113.2 ± 10.8 | 115.8 ± 11.1 | 111.3 ± 15.0 | 0.87 |
| RRdia (mmHg ± SD) | 79.7 ± 3.9 | 82.2 ± 19.6 | 63.7 ± 28.3 | 0.32 |
| HR (min-1 ± SD) | 73.8 ± 15.6 | 69.0 ± 11.4 | 78.0 ± 19.5 | 0.54 |
| CI (l/min/m2 ± SD) | 2.9 ± 0.9 | 2.3 ± 0.9 | 2.8 ± 0.9 | 0.52 |
| LVEF (% ± SD) | 20.7 ± 5.0 | 24.8 ± 8.3 | 21.7 ± 9.5 | 0.68 |
| LVEDVI (ml ± SD) | 129.9 ± 34.0 | 129.4 ± 38.6 | 160.8 ± 65.2 | 0.22 |
| LVESVI (ml ± SD) | 104.1 ± 28.4 | 97.3 ± 32.1 | 129.8 ± 66.4 | 0.22 |
| LVMMI | 71.5 ± 21.8 | 85.2 ± 21.5 | 107.5 ± 27.8 | 0.004 |
| LVMM/BSA-1.4 | 55.3 ± 17.6 | 63.5 ± 15.7 | 79.3 ± 21.3 | 0.01 |
| RVEF (% ± SD) | 24.7 ± 10.2 | 34.3 ± 13.6 | 24.7 ± 10.5 | 0.08 |
| RVEDVI (ml ± SD) | 63.8 ± 16.9 | 77.8 ± 14.2 | 88.5 ± 22.3 | 0.10 |
| RVESVI (ml ± SD) | 48.9 ± 16.6 | 51.8 ± 15.4 | 64.9 ± 21.9 | 0.07 |
Abbreviations see Table 1.
Figure 1Correlation of RVMM/RVEDV-index and LVMM/LVEDV-index in IDC patients.
Figure 2Correlation of RVMMI and LVMMI (muscle mass normalized to body surface area).
Correlates of different right ventricular mass (RVMM) indices.
| RVMM-AI | RVMMI (g/m2) | IVMR | ||||
|---|---|---|---|---|---|---|
| r = | p = | r = | p = | r = | p = | |
| LVMM/BSA-1.4 | 0.52 | 0.002 | 0.52 | 0.001 | ns | ns |
| LVMMI | 0.59 | <.001 | 0.6 | <.001 | ns | ns |
| LVEF (%) | ns | ns | ns | ns | ns | ns |
| RVEF (%) | ns | ns | ns | ns | ns | ns |
| RVEDVI | 0.44 | 0.01 | 0.44 | 0.009 | 0.6 | <.001 |
| RVESVI | ns | ns | 0.34 | 0.049 | 0.59 | <.001 |
| PAMP (mmHg) | 0.39 | 0.03 | 0.39 | 0.03 | 0.57 | 0.001 |
| PCWP (mmHg) | ns | ns | ns | ns | 0.36 | 0.04 |
| NYHA class | 0.41 | 0.02 | 0.42 | 0.02 | ns | ns |
| Heart rate (min-1) | ns | ns | 0.46 | 0.04 | ns | ns |
Abbreviations see Table 1.
Correlation of muscle mass and muscle mass indices to IVMR (RVMM/LVMM ratio).
| Parameter | Correlation | Significance |
|---|---|---|
| RVMM (g) | 0.79 | < 0.001 |
| LVMM (g) | 0.17 | 0.32 |
| RVMMI (g/m2) | 0.80 | < 0.001 |
| RVMM-AI | 0.77 | < 0.001 |
| LVMMI (g/m2) | 0.06 | 0.75 |
| LVMM/BSA-1.4 | -0.08 | 0.64 |
| Total muscle mass (g) | 0.39 | 0.02 |
Abbreviations see Table 1.
Figure 3Correlation of pulmonary artery mean pressure and the interventricular mass ration (IVMR) in IDC-patients.
Figure 4Correlation of LVMM and RVMM/ LVMM-ratio in IDC patients.
Results of stepwise multivariate regression analysis.
| Coefficient | Std. Error | p Value | |
| (Constant) | -1.4 | 0.63 | 0.03 |
| LVMM/BSA-1.4 | 0.037 | 0.008 | <.001 |
| PAMP (mmHg) | 0.05 | 0.013 | <.001 |
| Coefficient | Std. Error | p Value | |
| (Constant) | 10.67 | 4.4 | 0.024 |
| PAMP (mmHg) | 0.90 | 0.24 | 0.001 |
Abbreviations see Table 1.